Strides Pharma — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of Strides Pharma holds 29.00% of the company. At a market capitalisation of ₹9.56k cr, that holding is worth ₹2.77k cr.

Promoter stake

29.00%

Value of holding

₹2.77k cr

Market cap

₹9.56k cr

Stake change

-0.60%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q3-2021
29.60%—
Q4-2021
29.60%—
Q1-2022
30.60%—
Q2-2022
30.37%—
Q3-2022
31.07%—
Q4-2022
30.89%—
Q1-2023
28.27%—
Q2-2023
28.07%—
Q3-2023
27.78%—
Q4-2023
27.39%—
Q1-2024
25.88%—
Q2-2024
25.86%—
Q3-2024
25.84%—
Q4-2024
26.82%—
Q1-2025
28.30%—
Q2-2025
28.30%—
Q3-2025
27.86%—
Q4-2025
27.86%—
Q1-2026
27.91%—
Q2-2026
27.91%—
Q3-2026
29.00%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is Strides Pharma's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.